(Stearyl, Norleucine17) VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells
- 1 September 1997
- journal article
- Published by Elsevier in Life Sciences
- Vol. 61 (17) , 1657-1666
- https://doi.org/10.1016/s0024-3205(97)00771-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Structure‐activity studies on the vasoactive intestinal peptide pharmacophoreInternational Journal of Peptide and Protein Research, 1995
- Multiple receptors for PACAP and VIPTrends in Pharmacological Sciences, 1994
- Differential signal transduction by five splice variants of the PACAP receptorNature, 1993
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratPeptides, 1991
- Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblastsNature, 1990
- Vasoactive Intestinal Peptide Receptors in Pancreas and Liver. Structure-Function RelationshipAnnals of the New York Academy of Sciences, 1988
- Interaction of Growth Hormone-Releasing Factor (GRF) and 14 GRF Analogs with Vasoactive Intestinal Peptide (VIP) Receptors of Rat Pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(l-29)-NH2as a VIP Antagonist*Endocrinology, 1985
- Structure-activity studies on the N-terminal region of growth hormone releasing factorJournal of Medicinal Chemistry, 1985
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970